Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome.

Jackevicius CA, Tu JV, Krumholz HM, Austin PC, Ross JS, Stukel TA, Koh M, Chong A, Ko DT.

J Am Heart Assoc. 2016 Apr 19;5(4):e003350. doi: 10.1161/JAHA.116.003350.

2.

Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure.

Liao PA, Lin G, Tsai SY, Wang CH, Juan YH, Lin YC, Wu MT, Yang LY, Liu MH, Chang TC, Lin YC, Huang YC, Huang PC, Wang JJ, Ng SH, Ng KK.

J Cardiovasc Magn Reson. 2016 Feb 5;18:9. doi: 10.1186/s12968-016-0228-3.

3.

Glucose uptake and lipid metabolism are impaired in epicardial adipose tissue from heart failure patients with or without diabetes.

Burgeiro A, Fuhrmann A, Cherian S, Espinoza D, Jarak I, Carvalho RA, Loureiro M, Patrício M, Antunes M, Carvalho E.

Am J Physiol Endocrinol Metab. 2016 Apr 1;310(7):E550-64. doi: 10.1152/ajpendo.00384.2015. Epub 2016 Jan 26.

4.

Altered Metabolic Profile With Sodium-Restricted Dietary Approaches to Stop Hypertension Diet in Hypertensive Heart Failure With Preserved Ejection Fraction.

Mathew AV, Seymour EM, Byun J, Pennathur S, Hummel SL.

J Card Fail. 2015 Dec;21(12):963-7. doi: 10.1016/j.cardfail.2015.10.003. Epub 2015 Oct 20.

5.

Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids.

Zhang K, Liu Y, Liu X, Chen J, Cai Q, Wang J, Huang H.

Oncotarget. 2015 Sep 22;6(28):24699-708. doi: 10.18632/oncotarget.5084.

6.

1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients.

Du Z, Shen A, Huang Y, Su L, Lai W, Wang P, Xie Z, Xie Z, Zeng Q, Ren H, Xu D.

PLoS One. 2014 Feb 5;9(2):e88102. doi: 10.1371/journal.pone.0088102. eCollection 2014.

7.

Freshly isolated mitochondria from failing human hearts exhibit preserved respiratory function.

Cordero-Reyes AM, Gupte AA, Youker KA, Loebe M, Hsueh WA, Torre-Amione G, Taegtmeyer H, Hamilton DJ.

J Mol Cell Cardiol. 2014 Mar;68:98-105. doi: 10.1016/j.yjmcc.2013.12.029. Epub 2014 Jan 9.

8.

Stenting and medical therapy for atherosclerotic renal-artery stenosis.

Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators.

N Engl J Med. 2014 Jan 2;370(1):13-22. doi: 10.1056/NEJMoa1310753. Epub 2013 Nov 18.

9.

Thyroid hormone reverses aging-induced myocardial fatty acid oxidation defects and improves the response to acutely increased afterload.

Ledee D, Portman MA, Kajimoto M, Isern N, Olson AK.

PLoS One. 2013 Jun 7;8(6):e65532. doi: 10.1371/journal.pone.0065532. Print 2013.

10.

Diabetic cardiomyopathy: bench to bedside.

Schilling JD, Mann DL.

Heart Fail Clin. 2012 Oct;8(4):619-31. doi: 10.1016/j.hfc.2012.06.007. Epub 2012 Aug 9. Review.

11.

A differing role of oxidative stress in the regulation of central and peripheral hemodynamics during exercise in heart failure.

Witman MA, McDaniel J, Fjeldstad AS, Ives SJ, Zhao J, Nativi JN, Stehlik J, Wray DW, Richardson RS.

Am J Physiol Heart Circ Physiol. 2012 Nov 15;303(10):H1237-44. doi: 10.1152/ajpheart.00568.2012. Epub 2012 Sep 7.

12.

Relationship between atorvastatin dose and the harm caused by torcetrapib.

Barter PJ, Rye KA, Beltangady MS, Ports WC, Duggan WT, Boekholdt SM, DeMicco DA, Kastelein JJ, Shear CL.

J Lipid Res. 2012 Nov;53(11):2436-42. doi: 10.1194/jlr.P026328. Epub 2012 Sep 2.

13.

Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond.

Witman MA, Fjeldstad AS, McDaniel J, Ives SJ, Zhao J, Barrett-O'Keefe Z, Nativi JN, Stehlik J, Wray DW, Richardson RS.

Hypertension. 2012 Sep;60(3):659-68. doi: 10.1161/HYPERTENSIONAHA.112.193318. Epub 2012 Jul 2.

14.

Increased expression of fatty-acid and calcium metabolism genes in failing human heart.

García-Rúa V, Otero MF, Lear PV, Rodríguez-Penas D, Feijóo-Bandín S, Noguera-Moreno T, Calaza M, Álvarez-Barredo M, Mosquera-Leal A, Parrington J, Brugada J, Portolés M, Rivera M, González-Juanatey JR, Lago F.

PLoS One. 2012;7(6):e37505. doi: 10.1371/journal.pone.0037505. Epub 2012 Jun 6.

15.

Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure.

Chokshi A, Drosatos K, Cheema FH, Ji R, Khawaja T, Yu S, Kato T, Khan R, Takayama H, Knöll R, Milting H, Chung CS, Jorde U, Naka Y, Mancini DM, Goldberg IJ, Schulze PC.

Circulation. 2012 Jun 12;125(23):2844-53. doi: 10.1161/CIRCULATIONAHA.111.060889. Epub 2012 May 14.

16.

Nonesterified fatty acids and risk of sudden cardiac death in older adults.

Djoussé L, Biggs ML, Ix JH, Kizer JR, Lemaitre RN, Sotoodehnia N, Zieman SJ, Mozaffarian D, Tracy RP, Mukamal KJ, Siscovick DS.

Circ Arrhythm Electrophysiol. 2012 Apr;5(2):273-8. doi: 10.1161/CIRCEP.111.967661. Epub 2012 Jan 26.

17.

Altered systemic ketone body metabolism in advanced heart failure.

Janardhan A, Chen J, Crawford PA.

Tex Heart Inst J. 2011;38(5):533-8.

18.

Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans.

Peterson LR, Saeed IM, McGill JB, Herrero P, Schechtman KB, Gunawardena R, Recklein CL, Coggan AR, DeMoss AJ, Dence CS, Gropler RJ.

Obesity (Silver Spring). 2012 Apr;20(4):802-10. doi: 10.1038/oby.2011.208. Epub 2011 Aug 4.

19.

Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.

Obrzut S, Tiongson J, Jamshidi N, Phan HM, Hoh C, Birgersdotter-Green U.

J Cardiovasc Transl Res. 2010 Dec;3(6):643-51. doi: 10.1007/s12265-010-9223-5. Epub 2010 Sep 15.

20.

Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart.

Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ, Neufer PD.

J Am Coll Cardiol. 2009 Nov 10;54(20):1891-8. doi: 10.1016/j.jacc.2009.07.031.

Supplemental Content

Loading ...
Support Center